FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2086702949> ?p ?o ?g. }

• W2086702949 endingPage "2399" @default.
• W2086702949 startingPage "2391" @default.
• W2086702949 abstract "Abstract Hepatocellular carcinoma (HCC) is associated with a poor prognosis due to late diagnoses and a lack of effective treatment options. Epidermal growth factor receptor (EGFR)–targeted therapies have been effective in other cancers. However, erlotinib and cetuximab have shown only modest efficacy in clinical trials of HCC. We examined epithelial-to-mesenchymal transition (EMT) as a determinant of sensitivity of HCC to EGFR inhibitors. A panel of 12 human hepatoma cell lines were classified as epithelial or mesenchymal based on their expression of E-cadherin and vimentin. The resulting classification correlated with a previous microarray analysis of human hepatoma cell lines whereby the mesenchymal cell lines were shown to have increased expression of genes involved in metastasis and invasion. Sensitivity to erlotinib, gefitinib, and cetuximab was assessed and the epithelial cell lines were found to be significantly more susceptible to all three agents. Analysis of the EGFR pathway showed that EMT status was independent of EGFR expression or downstream extracellular signal–regulated kinase activation and only the epithelial cell lines expressed ErbB3. Interestingly, mesenchymal cells resistant to EGFR inhibitors had increased AKT and signal transducer and activator of transcription-3 activation through elevated expression of integrin-linked kinase (ILK). Mesenchymal cell lines were therefore experimentally transformed with kinase-inactive ILK (KI-ILK) with a resulting decrease in ILK activity and activation of AKT. KI-ILK transformants showed increased sensitivity to EGFR inhibitors both in vitro and in an in vivo xenograft model. These data suggest that EMT predicts HCC sensitivity to EGFR-targeted therapies and that ILK is a novel target to overcome HCC resistance to EGFR inhibition. [Cancer Res 2008;68(7):2391–9]" @default.
• W2086702949 created "2016-06-24" @default.
• W2086702949 creator A5002128457 @default.
• W2086702949 creator A5041668548 @default.
• W2086702949 creator A5043519976 @default.
• W2086702949 creator A5047606517 @default.
• W2086702949 creator A5050196145 @default.
• W2086702949 creator A5068858118 @default.
• W2086702949 creator A5088566246 @default.
• W2086702949 date "2008-04-01" @default.
• W2086702949 modified "2023-10-03" @default.
• W2086702949 title "Epithelial-to-Mesenchymal Transition and Integrin-Linked Kinase Mediate Sensitivity to Epidermal Growth Factor Receptor Inhibition in Human Hepatoma Cells" @default.
• W2086702949 cites W1539015594 @default.
• W2086702949 cites W1971747822 @default.
• W2086702949 cites W1973890143 @default.
• W2086702949 cites W1975602357 @default.
• W2086702949 cites W1987473368 @default.
• W2086702949 cites W1988442083 @default.
• W2086702949 cites W1989911225 @default.
• W2086702949 cites W1993919875 @default.
• W2086702949 cites W2007685062 @default.
• W2086702949 cites W2008182675 @default.
• W2086702949 cites W2020509813 @default.
• W2086702949 cites W2020830322 @default.
• W2086702949 cites W2023815439 @default.
• W2086702949 cites W2024774077 @default.
• W2086702949 cites W2039298921 @default.
• W2086702949 cites W2039633811 @default.
• W2086702949 cites W2042103473 @default.
• W2086702949 cites W2043696829 @default.
• W2086702949 cites W2044404885 @default.
• W2086702949 cites W2045027538 @default.
• W2086702949 cites W2045147990 @default.
• W2086702949 cites W2050108686 @default.
• W2086702949 cites W2060136332 @default.
• W2086702949 cites W2064914836 @default.
• W2086702949 cites W2071058106 @default.
• W2086702949 cites W2073195217 @default.
• W2086702949 cites W2098455835 @default.
• W2086702949 cites W2099789788 @default.
• W2086702949 cites W2100189272 @default.
• W2086702949 cites W2106036268 @default.
• W2086702949 cites W2111599976 @default.
• W2086702949 cites W2115497785 @default.
• W2086702949 cites W2119073457 @default.
• W2086702949 cites W2119389886 @default.
• W2086702949 cites W2121389240 @default.
• W2086702949 cites W2123027432 @default.
• W2086702949 cites W2123213003 @default.
• W2086702949 cites W2124471593 @default.
• W2086702949 cites W2132395321 @default.
• W2086702949 cites W2136040107 @default.
• W2086702949 cites W2138610774 @default.
• W2086702949 cites W2144459759 @default.
• W2086702949 cites W2160866033 @default.
• W2086702949 cites W2161821474 @default.
• W2086702949 cites W2163717842 @default.
• W2086702949 cites W2167341806 @default.
• W2086702949 cites W2167620731 @default.
• W2086702949 cites W2325413783 @default.
• W2086702949 doi "https://doi.org/10.1158/0008-5472.can-07-2460" @default.
• W2086702949 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/18381447" @default.
• W2086702949 hasPublicationYear "2008" @default.
• W2086702949 type Work @default.
• W2086702949 sameAs 2086702949 @default.
• W2086702949 citedByCount "285" @default.
• W2086702949 countsByYear W20867029492012 @default.
• W2086702949 countsByYear W20867029492013 @default.
• W2086702949 countsByYear W20867029492014 @default.
• W2086702949 countsByYear W20867029492015 @default.
• W2086702949 countsByYear W20867029492016 @default.
• W2086702949 countsByYear W20867029492017 @default.
• W2086702949 countsByYear W20867029492018 @default.
• W2086702949 countsByYear W20867029492019 @default.
• W2086702949 countsByYear W20867029492020 @default.
• W2086702949 countsByYear W20867029492021 @default.
• W2086702949 countsByYear W20867029492022 @default.
• W2086702949 countsByYear W20867029492023 @default.
• W2086702949 crossrefType "journal-article" @default.
• W2086702949 hasAuthorship W2086702949A5002128457 @default.
• W2086702949 hasAuthorship W2086702949A5041668548 @default.
• W2086702949 hasAuthorship W2086702949A5043519976 @default.
• W2086702949 hasAuthorship W2086702949A5047606517 @default.
• W2086702949 hasAuthorship W2086702949A5050196145 @default.
• W2086702949 hasAuthorship W2086702949A5068858118 @default.
• W2086702949 hasAuthorship W2086702949A5088566246 @default.
• W2086702949 hasConcept C115456853 @default.
• W2086702949 hasConcept C121608353 @default.
• W2086702949 hasConcept C126322002 @default.
• W2086702949 hasConcept C147447768 @default.
• W2086702949 hasConcept C184235292 @default.
• W2086702949 hasConcept C185592680 @default.
• W2086702949 hasConcept C198826908 @default.
• W2086702949 hasConcept C203014093 @default.
• W2086702949 hasConcept C204232928 @default.
• W2086702949 hasConcept C2777506169 @default.
• W2086702949 hasConcept C2778087573 @default.
• W2086702949 hasConcept C2779013556 @default.

• next